Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
679.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.295%)
Market Cap: £1.25b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Investor Presentation

9 Nov 2020 07:00

RNS Number : 5883E
Volex PLC
09 November 2020
 

9 November 2020

Volex plc

("Volex" or the "Company")

Investor Presentation

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is pleased to announce that Executive Chairman Nat Rothschild and Chief Financial Officer Daren Morris will provide a live presentation relating to the Company's half-year results via the Investor Meet Company platform on Thursday 12 November 2020 at 11 am.

The Company is committed to ensuring that there are appropriate communication structures for all elements of its shareholder base so that its strategy, business model and performance are clearly understood.

 

· The online presentation is open to all existing and potential shareholders.

 

· Questions can be submitted pre-event via your IMC dashboard or any time during the live presentation via the "Ask a Question" function. Although the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.

 

· Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.

 

Investors can sign up to Investor Meet Company for free and "add to meet" Volex plc via:

 

https://www.investormeetcompany.com/volex-plc/register-investor

 

Investors who have already registered and added to meet the Company will be automatically invited.

 

For further information please contact:

 

Volex plc

+44 (0)7909 995 887

Nat Rothschild, Executive Chairman

Daren Morris, Chief Financial Officer

 

N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

Iqra Amin

 

Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich

 

Powerscourt - Media Enquiries

 

+44 (0)20 7250 1446

James White

Jack Holden

 

NOTES TO EDITORS:

Volex plc (AIM:VLX) is a leading integrated manufacturing specialist. The Group designs and manufactures products that ensure a critical connection never fails and are used in everything from defibrillators and ventilators through to data networking equipment and vehicle telematics. Headquartered in the United Kingdom, Volex serves the needs of its blue-chip customer base from its manufacturing sites located across nine countries and three continents, employing over 6,000 people. Volex's products are sold through its own global sales force and through distributors to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services companies. For more information please visit www.volex.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBPBFTMTTMBFM
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.